CA Patent

CA2428647A1 — Synergistic combinations comprising a renin inhibitor for cardiovascular diseases

Assigned to Novartis AG · Expires 2002-05-23 · 24y expired

What this patent protects

The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.

USPTO Abstract

The invention relates to a combination comprising the renin inhibitor of formula (I) or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number: CA2428647A1
Jurisdiction: CA
Classification: —
Expires: 2002-05-23
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.